Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-11-09

Clinical Trial Update: Electrical Inhibition (EI): A Preliminary Study To Inhibit Preterm Labor And Preterm Birth [Phase 1]

View source ↗

Summary

This document reports the withdrawal of a Phase 1 clinical trial evaluating Electrical Inhibition to prevent preterm labor and birth.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NYU Langone Health | Conditions: Premature Birth, Premature Labor | Phase 1 | Status: WITHDRAWN